12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Synthesis and biological evaluation of a novel pyroglutamyl-modified TRH analogue.

      Farmaco (Società chimica italiana : 1989)
      Animals, Cattle, Cells, Cultured, Dopamine, secretion, Dose-Response Relationship, Drug, Male, Nuclear Magnetic Resonance, Biomolecular, Pituitary Gland, Anterior, drug effects, metabolism, Prolactin, Pyroglutamyl-Peptidase I, Pyrrolidonecarboxylic Acid, chemical synthesis, chemistry, pharmacology, Rats, Rats, Wistar, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, methods, Thyrotropin-Releasing Hormone, analogs & derivatives

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The TRH analogue 3, incorporating the (S)-isothiazolidine-1,1-dioxide-3-carboxylic acid (1) moiety in place of the native L-pyroglutamic acid (pGlu) residue, has been synthesized and fully characterized by 1H and 13C NMR. The effects of replacing pGlu with its sulphonamido counterpart on biological activity have been investigated. This peptide, which is significantly stabilized towards hydrolysis by pyroglutamyl peptidase type I (PP I, EC 3.4.19.3), has shown to maintain in vitro prolactin-releasing activity.

          Related collections

          Author and article information

          Comments

          Comment on this article